Literature DB >> 11936950

Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer.

Kevin Morgan1, Peter Marsters, Stephen Morley, Diana van Gent, Ala Hejazi, Matt Backx, Emma R K Thorpe, Noor Kalsheker.   

Abstract

alpha(1)-Antitrypsin (AAT) is the major serine proteinase inhibitor (SERPIN A1) in human plasma. Its target proteinase is neutrophil elastase and its main physiological function is protection of the lower respiratory tract from the destructive effects of neutrophil elastase during an inflammatory response. Circulating levels of AAT rise 2-3-fold during inflammation and the liver produces most of this increase. The cytokines oncostatin M (OSM) and interleukin-6 have been shown to be mainly responsible for this effect, which is mediated via the interaction of cytokine-inducible transcription factors with regulatory elements within the gene. In the present study, we report for the first time that OSM stimulation of hepatocyte AAT occurs via an interaction between the hepatocyte promoter and an OSM-responsive element at the 3'-end of the AAT gene. This effect is mediated by the transcription factor signal transducer and activator of transcription 3 ('STAT 3') binding to an OSM-responsive element (sequence TTCTCTTAA), and this site is distinct from, but close to, a previously reported interleukin-6-responsive element.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936950      PMCID: PMC1222683          DOI: 10.1042/BJ20011312

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Tissue-specific expression of the human alpha 1-antitrypsin gene is controlled by multiple cis-regulatory elements.

Authors:  R F Shen; Y Li; R N Sifers; H Wang; C Hardick; S Y Tsai; S L Woo
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

Review 2.  Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.

Authors:  G L Long; T Chandra; S L Woo; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

Review 4.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

5.  Exclusion of an exon in monocyte alpha-1-antitrypsin mRNA after stimulation of U937 cells by interleukin-6.

Authors:  N Kalsheker; T Swanson
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

6.  Cell-specific expression of a transfected human alpha 1-antitrypsin gene.

Authors:  G Ciliberto; L Dente; R Cortese
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

7.  Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals.

Authors:  J F Mornex; A Chytil-Weir; Y Martinet; M Courtney; J P LeCocq; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  Cis- and trans-acting elements responsible for the cell-specific expression of the human alpha 1-antitrypsin gene.

Authors:  V De Simone; G Ciliberto; E Hardon; G Paonessa; F Palla; L Lundberg; R Cortese
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

9.  Lipopolysaccharide modulates the expression of alpha 1 proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages.

Authors:  C Barbey-Morel; J A Pierce; E J Campbell; D H Perlmutter
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes.

Authors:  E Perlino; R Cortese; G Ciliberto
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  6 in total

1.  Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells.

Authors:  Ying-Hua Chang; Shu-Hui Lee; I-Chuang Liao; Shin-Huei Huang; Hung-Chi Cheng; Pao-Chi Liao
Journal:  Mol Cell Proteomics       Date:  2012-08-15       Impact factor: 5.911

2.  Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer.

Authors:  Chae Hwa Kwon; Hye Ji Park; Jin Hwa Choi; Ja Rang Lee; Hye Kyung Kim; Hong-Jae Jo; Hyun Sung Kim; Nahmgun Oh; Geun Am Song; Do Youn Park
Journal:  Oncotarget       Date:  2015-08-21

Review 3.  Leptin Resistance: A Possible Interface Between Obesity and Pulmonary-Related Disorders.

Authors:  Abdul Rehman Khan; Fazli Rabbi Awan
Journal:  Int J Endocrinol Metab       Date:  2016-02-12

4.  Plasma α1-antitrypsin: a neglected predictor of angiographic severity in patients with stable angina pectoris.

Authors:  Hui Zhao; Hong Liu; Lin Chai; Ping Xu; Lu Hua; Xiao-Yuan Guan; Bing Duan; Yi-Ling Huang; Yi-Shi Li
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

5.  Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.

Authors:  Michael H Cho; Merry-Lynn N McDonald; Xiaobo Zhou; Manuel Mattheisen; Peter J Castaldi; Craig P Hersh; Dawn L Demeo; Jody S Sylvia; John Ziniti; Nan M Laird; Christoph Lange; Augusto A Litonjua; David Sparrow; Richard Casaburi; R Graham Barr; Elizabeth A Regan; Barry J Make; John E Hokanson; Sharon Lutz; Tanda Murray Dudenkov; Homayoon Farzadegan; Jacqueline B Hetmanski; Ruth Tal-Singer; David A Lomas; Per Bakke; Amund Gulsvik; James D Crapo; Edwin K Silverman; Terri H Beaty
Journal:  Lancet Respir Med       Date:  2014-02-07       Impact factor: 30.700

6.  Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease.

Authors:  Gema Gómez-Mariano; Nerea Matamala; Selene Martínez; Iago Justo; Alberto Marcacuzco; Carlos Jimenez; Sara Monzón; Isabel Cuesta; Cristina Garfia; María Teresa Martínez; Meritxell Huch; Ignacio Pérez de Castro; Manuel Posada; Sabina Janciauskiene; Beatriz Martínez-Delgado
Journal:  Hepatol Int       Date:  2019-12-13       Impact factor: 6.047

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.